Concepts (196)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Transfusion Reaction | 3 | 2018 | 245 | 0.92 | Why? |
| Blood Transfusion | 6 | 2019 | 1399 | 0.67 | Why? |
| Blood Grouping and Crossmatching | 1 | 2017 | 125 | 0.63 | Why? |
| Pregnancy Complications, Hematologic | 1 | 2018 | 114 | 0.63 | Why? |
| Anemia, Sickle Cell | 2 | 2018 | 546 | 0.56 | Why? |
| Erythrocyte Transfusion | 4 | 2019 | 386 | 0.55 | Why? |
| Genotyping Techniques | 1 | 2017 | 360 | 0.54 | Why? |
| Pathology, Clinical | 1 | 2017 | 407 | 0.47 | Why? |
| Hematology | 1 | 2018 | 649 | 0.44 | Why? |
| Infant, Very Low Birth Weight | 3 | 2019 | 62 | 0.42 | Why? |
| Enterocolitis, Necrotizing | 2 | 2019 | 71 | 0.37 | Why? |
| Transfusion Medicine | 2 | 2021 | 101 | 0.36 | Why? |
| Infant, Premature, Diseases | 2 | 2019 | 74 | 0.36 | Why? |
| Blood Donors | 2 | 2021 | 2956 | 0.30 | Why? |
| Thrombocytopenia | 1 | 2018 | 2093 | 0.28 | Why? |
| Graft vs Host Disease | 3 | 2018 | 501 | 0.27 | Why? |
| Communicable Diseases | 1 | 2018 | 2148 | 0.25 | Why? |
| Erythrocytes | 2 | 2018 | 617 | 0.23 | Why? |
| Oligosaccharides | 1 | 2021 | 69 | 0.22 | Why? |
| Georgia | 3 | 2021 | 955 | 0.21 | Why? |
| ABO Blood-Group System | 2 | 2021 | 995 | 0.21 | Why? |
| Blood Viscosity | 1 | 2020 | 71 | 0.21 | Why? |
| Bronchopulmonary Dysplasia | 1 | 2019 | 53 | 0.19 | Why? |
| Platelet Transfusion | 2 | 2018 | 209 | 0.19 | Why? |
| Immunization, Passive | 5 | 2021 | 10067 | 0.18 | Why? |
| Hemoglobin, Sickle | 1 | 2017 | 23 | 0.18 | Why? |
| Mass Screening | 1 | 2018 | 8005 | 0.18 | Why? |
| Isoantibodies | 1 | 2018 | 134 | 0.17 | Why? |
| ADP-ribosyl Cyclase 1 | 1 | 2017 | 96 | 0.17 | Why? |
| Blood | 1 | 2018 | 274 | 0.17 | Why? |
| Blood Preservation | 1 | 2018 | 191 | 0.16 | Why? |
| Neuropathology | 1 | 2017 | 95 | 0.16 | Why? |
| Theranostic Nanomedicine | 1 | 2017 | 143 | 0.16 | Why? |
| Hemolysis | 1 | 2018 | 283 | 0.15 | Why? |
| Pathology, Surgical | 1 | 2017 | 107 | 0.15 | Why? |
| Infant, Premature | 1 | 2019 | 883 | 0.13 | Why? |
| Plasma Exchange | 1 | 2020 | 763 | 0.13 | Why? |
| Biotechnology | 1 | 2017 | 444 | 0.13 | Why? |
| Alveolar Epithelial Cells | 1 | 2021 | 1445 | 0.12 | Why? |
| Decision Support Systems, Clinical | 1 | 2018 | 551 | 0.12 | Why? |
| Flagellin | 1 | 2011 | 22 | 0.12 | Why? |
| Toll-Like Receptor 5 | 1 | 2011 | 38 | 0.12 | Why? |
| Cytomegalovirus | 1 | 2017 | 600 | 0.11 | Why? |
| Anemia | 1 | 2019 | 789 | 0.11 | Why? |
| Clinical Laboratory Techniques | 1 | 2018 | 23402 | 0.11 | Why? |
| Hematopoietic Stem Cell Transplantation | 2 | 2018 | 2426 | 0.11 | Why? |
| Intestinal Mucosa | 1 | 2019 | 1046 | 0.11 | Why? |
| Bibliometrics | 1 | 2018 | 731 | 0.10 | Why? |
| Hip Fractures | 1 | 2018 | 667 | 0.10 | Why? |
| Convalescence | 1 | 2021 | 2829 | 0.10 | Why? |
| Herpesviridae Infections | 1 | 2011 | 172 | 0.10 | Why? |
| Immunoglobulin A | 1 | 2021 | 3567 | 0.10 | Why? |
| Immunoglobulin M | 3 | 2021 | 9091 | 0.09 | Why? |
| Hemorrhagic Fever, Ebola | 1 | 2020 | 1475 | 0.09 | Why? |
| Enzyme-Linked Immunosorbent Assay | 2 | 2021 | 7868 | 0.09 | Why? |
| Immunoglobulin G | 3 | 2021 | 21571 | 0.09 | Why? |
| Membrane Glycoproteins | 1 | 2017 | 2273 | 0.09 | Why? |
| Immunoglobulins, Intravenous | 1 | 2020 | 2705 | 0.09 | Why? |
| Point-of-Care Systems | 1 | 2021 | 2955 | 0.09 | Why? |
| Multiple Myeloma | 1 | 2017 | 1064 | 0.08 | Why? |
| Down Syndrome | 2 | 2021 | 397 | 0.08 | Why? |
| Humans | 28 | 2021 | 930598 | 0.08 | Why? |
| T-Cell Antigen Receptor Specificity | 1 | 2005 | 93 | 0.07 | Why? |
| Occupational Diseases | 1 | 2021 | 2787 | 0.07 | Why? |
| Transplantation, Homologous | 3 | 2018 | 757 | 0.07 | Why? |
| Pneumonia, Viral | 4 | 2021 | 243684 | 0.07 | Why? |
| Research Design | 2 | 2018 | 5830 | 0.07 | Why? |
| Severity of Illness Index | 3 | 2021 | 48226 | 0.06 | Why? |
| Heart Diseases | 1 | 2020 | 3503 | 0.06 | Why? |
| Patient Safety | 1 | 2018 | 4885 | 0.06 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.06 | Why? |
| Specimen Handling | 1 | 2020 | 6190 | 0.06 | Why? |
| Antibodies, Viral | 5 | 2021 | 51949 | 0.06 | Why? |
| Occupational Exposure | 1 | 2021 | 4742 | 0.06 | Why? |
| Galectin 4 | 1 | 2021 | 9 | 0.06 | Why? |
| Oligosaccharides, Branched-Chain | 1 | 2021 | 11 | 0.06 | Why? |
| Heart Septal Defects | 1 | 2021 | 40 | 0.06 | Why? |
| Carbohydrate Conformation | 1 | 2021 | 46 | 0.06 | Why? |
| Bone Marrow Transplantation | 1 | 2005 | 343 | 0.06 | Why? |
| Carbohydrate Sequence | 1 | 2021 | 54 | 0.06 | Why? |
| Organ Transplantation | 1 | 2017 | 2616 | 0.06 | Why? |
| Consensus Sequence | 1 | 2021 | 81 | 0.06 | Why? |
| Nephelometry and Turbidimetry | 1 | 2020 | 25 | 0.06 | Why? |
| Universities | 1 | 2017 | 4374 | 0.06 | Why? |
| Erythrocyte Membrane | 1 | 2021 | 56 | 0.06 | Why? |
| Galectins | 1 | 2021 | 109 | 0.05 | Why? |
| Pandemics | 6 | 2021 | 389249 | 0.05 | Why? |
| Zonula Occludens-1 Protein | 1 | 2019 | 54 | 0.05 | Why? |
| Anemia, Neonatal | 1 | 2018 | 3 | 0.05 | Why? |
| Evaluation Studies as Topic | 1 | 2020 | 391 | 0.05 | Why? |
| Pregnancy | 2 | 2019 | 23879 | 0.05 | Why? |
| Splanchnic Circulation | 1 | 2018 | 37 | 0.05 | Why? |
| Substrate Specificity | 1 | 2021 | 639 | 0.05 | Why? |
| Kidney Transplantation | 1 | 2018 | 5397 | 0.04 | Why? |
| Kentucky | 1 | 2018 | 125 | 0.04 | Why? |
| Sequence Homology, Amino Acid | 1 | 2021 | 945 | 0.04 | Why? |
| National Institutes of Health (U.S.) | 1 | 2020 | 443 | 0.04 | Why? |
| Female | 13 | 2021 | 380317 | 0.04 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2021 | 9706 | 0.04 | Why? |
| Antibodies, Monoclonal | 1 | 2017 | 8041 | 0.04 | Why? |
| Public-Private Sector Partnerships | 1 | 2020 | 259 | 0.04 | Why? |
| Inventions | 1 | 2020 | 372 | 0.04 | Why? |
| Health Services Accessibility | 1 | 2020 | 10697 | 0.04 | Why? |
| Organ Specificity | 1 | 2021 | 1070 | 0.04 | Why? |
| Maryland | 1 | 2018 | 436 | 0.04 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.04 | Why? |
| Fracture Fixation, Internal | 1 | 2018 | 188 | 0.04 | Why? |
| Critical Illness | 1 | 2020 | 17281 | 0.04 | Why? |
| New Jersey | 1 | 2018 | 528 | 0.04 | Why? |
| Sensitivity and Specificity | 3 | 2021 | 22971 | 0.04 | Why? |
| Financing, Government | 1 | 2020 | 434 | 0.04 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.04 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.04 | Why? |
| Influenza, Human | 1 | 2020 | 10779 | 0.04 | Why? |
| Sequence Alignment | 1 | 2021 | 2109 | 0.03 | Why? |
| Spike Glycoprotein, Coronavirus | 2 | 2021 | 37182 | 0.03 | Why? |
| Treatment Outcome | 1 | 2020 | 51732 | 0.03 | Why? |
| Iron | 1 | 2019 | 619 | 0.03 | Why? |
| Infant, Newborn | 3 | 2019 | 23105 | 0.03 | Why? |
| Limit of Detection | 1 | 2021 | 2698 | 0.03 | Why? |
| Infant | 3 | 2021 | 30274 | 0.03 | Why? |
| Washington | 1 | 2018 | 1722 | 0.03 | Why? |
| Arthroplasty, Replacement, Hip | 1 | 2018 | 403 | 0.03 | Why? |
| Muromegalovirus | 1 | 2011 | 16 | 0.03 | Why? |
| 3T3 Cells | 1 | 2011 | 152 | 0.03 | Why? |
| Hemoglobins | 1 | 2018 | 958 | 0.03 | Why? |
| Multicenter Studies as Topic | 1 | 2019 | 2437 | 0.03 | Why? |
| Male | 10 | 2021 | 367725 | 0.03 | Why? |
| Adult | 8 | 2021 | 244371 | 0.03 | Why? |
| Blood Cell Count | 1 | 2017 | 1101 | 0.03 | Why? |
| Cost-Benefit Analysis | 1 | 2020 | 2259 | 0.03 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.03 | Why? |
| Reagent Kits, Diagnostic | 1 | 2020 | 2149 | 0.03 | Why? |
| Lung Injury | 1 | 2019 | 919 | 0.02 | Why? |
| United States | 3 | 2021 | 46150 | 0.02 | Why? |
| Middle Aged | 7 | 2021 | 270681 | 0.02 | Why? |
| Amino Acid Sequence | 1 | 2021 | 6049 | 0.02 | Why? |
| Mice | 3 | 2019 | 21357 | 0.02 | Why? |
| Interferon-gamma | 1 | 2019 | 2711 | 0.02 | Why? |
| Fatal Outcome | 1 | 2018 | 3438 | 0.02 | Why? |
| Protein Domains | 1 | 2021 | 6563 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2019 | 5440 | 0.02 | Why? |
| Point-of-Care Testing | 1 | 2020 | 2782 | 0.02 | Why? |
| T-Lymphocytes | 1 | 2005 | 6670 | 0.02 | Why? |
| Perioperative Care | 1 | 2018 | 1329 | 0.02 | Why? |
| Serologic Tests | 1 | 2021 | 4359 | 0.02 | Why? |
| Immunity, Humoral | 1 | 2021 | 4849 | 0.02 | Why? |
| Time Factors | 2 | 2020 | 31397 | 0.02 | Why? |
| Genetic Predisposition to Disease | 1 | 2021 | 4027 | 0.02 | Why? |
| Aged | 5 | 2021 | 215776 | 0.02 | Why? |
| Lymphopoiesis | 1 | 2005 | 26 | 0.02 | Why? |
| Hyaluronan Receptors | 1 | 2005 | 61 | 0.02 | Why? |
| Risk | 1 | 2018 | 5288 | 0.02 | Why? |
| Mice, Inbred Strains | 1 | 2005 | 136 | 0.02 | Why? |
| Immunoassay | 1 | 2021 | 4485 | 0.02 | Why? |
| CD8 Antigens | 1 | 2005 | 72 | 0.02 | Why? |
| Furocoumarins | 1 | 2005 | 67 | 0.02 | Why? |
| Cohort Studies | 2 | 2019 | 36005 | 0.02 | Why? |
| Oxygen | 1 | 2018 | 3715 | 0.02 | Why? |
| Prospective Studies | 2 | 2020 | 43301 | 0.02 | Why? |
| Thymus Gland | 1 | 2005 | 126 | 0.02 | Why? |
| Mice, Transgenic | 1 | 2011 | 2739 | 0.02 | Why? |
| Protein Binding | 1 | 2021 | 11430 | 0.02 | Why? |
| Survival Analysis | 1 | 2018 | 7592 | 0.02 | Why? |
| Antiviral Agents | 2 | 2020 | 41703 | 0.02 | Why? |
| Antigens, Viral | 1 | 2020 | 6298 | 0.02 | Why? |
| Retrospective Studies | 3 | 2021 | 105322 | 0.02 | Why? |
| Cross-Sectional Studies | 2 | 2021 | 53120 | 0.02 | Why? |
| Adenosine Monophosphate | 1 | 2020 | 5652 | 0.02 | Why? |
| Alanine | 1 | 2020 | 5687 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2019 | 11304 | 0.01 | Why? |
| Patient Discharge | 1 | 2018 | 5696 | 0.01 | Why? |
| Regeneration | 1 | 2005 | 429 | 0.01 | Why? |
| Case-Control Studies | 1 | 2020 | 17671 | 0.01 | Why? |
| Disease Progression | 1 | 2020 | 13580 | 0.01 | Why? |
| Hospitals | 1 | 2021 | 11793 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2019 | 10998 | 0.01 | Why? |
| Mice, Inbred BALB C | 1 | 2011 | 5814 | 0.01 | Why? |
| Mice, Inbred C57BL | 1 | 2011 | 5542 | 0.01 | Why? |
| Risk Factors | 2 | 2021 | 71621 | 0.01 | Why? |
| Animals | 3 | 2019 | 78931 | 0.01 | Why? |
| Respiratory Insufficiency | 1 | 2020 | 7301 | 0.01 | Why? |
| Aged, 80 and over | 2 | 2020 | 88759 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2018 | 10649 | 0.01 | Why? |
| Acute Disease | 1 | 2011 | 6029 | 0.01 | Why? |
| Cell Proliferation | 1 | 2005 | 1973 | 0.01 | Why? |
| Chronic Disease | 1 | 2011 | 5139 | 0.01 | Why? |
| Inflammation | 1 | 2019 | 13255 | 0.01 | Why? |
| Personal Protective Equipment | 1 | 2021 | 15978 | 0.01 | Why? |
| Immune System | 1 | 2005 | 1479 | 0.01 | Why? |
| Antibodies, Neutralizing | 1 | 2020 | 25288 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2021 | 43792 | 0.01 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.01 | Why? |
| Immunologic Memory | 1 | 2005 | 3362 | 0.01 | Why? |
| Incidence | 1 | 2011 | 25622 | 0.01 | Why? |
| Young Adult | 1 | 2018 | 93724 | 0.00 | Why? |
Roback's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(196)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(245)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_